Single reporter for targeted multimodal in vivo imaging.

We have developed a multifaceted, highly specific reporter for multimodal in vivo imaging and applied it for detection of brain tumors. A metabolically biotinylated, membrane-bound form of Gaussia luciferase was synthesized, termed mbGluc-biotin. We engineered glioma cells to express this reporter and showed that brain tumor formation can be temporally imaged by bioluminescence following systemic administration of coelenterazine. Brain tumors expressing this reporter had high sensitivity for detection by magnetic resonance and fluorescence tomographic imaging upon injection of streptavidin conjugated to magnetic nanoparticles or fluorophore, respectively. Moreover, single photon emission computed tomography showed enhanced imaging of these tumors upon injection with streptavidin complexed to (111)In-DTPA-biotin. This work shows for the first time a single small reporter (∼40 kDa) which can be monitored with most available molecular imaging modalities and can be extended for single cell imaging using intravital microscopy, allowing real-time tracking of any cell expressing it in vivo.

[1]  Christian E Badr,et al.  Bioluminescence imaging: progress and applications. , 2011, Trends in biotechnology.

[2]  Kami Kim,et al.  Bright and stable near infra-red fluorescent protein for in vivo imaging , 2011, Nature Biotechnology.

[3]  R. Weissleder,et al.  Enhanced in vivo imaging of metabolically biotinylated cell surface reporters. , 2011, Analytical chemistry.

[4]  P. Russell,et al.  Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? , 2010, Stem cells.

[5]  S. Ylä-Herttuala,et al.  Avidin-biotin technology in targeted therapy , 2010, Expert opinion on drug delivery.

[6]  J. Casal,et al.  Differential protein expression on the cell surface of colorectal cancer cells associated to tumor metastasis , 2010, Proteomics.

[7]  L. Josephson,et al.  Divergent oriented synthesis for the design of reagents for protein conjugation. , 2010, Journal of combinatorial chemistry.

[8]  Simon R Cherry,et al.  Multimodality imaging: beyond PET/CT and SPECT/CT. , 2009, Seminars in nuclear medicine.

[9]  Michel Sadelain,et al.  Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase , 2009, Nature Medicine.

[10]  Robin S. Dothager,et al.  Advances in bioluminescence imaging of live animal models. , 2009, Current opinion in biotechnology.

[11]  R. Weissleder,et al.  Simplified syntheses of complex multifunctional nanomaterials. , 2008, Chemical communications.

[12]  J. Willmann,et al.  Molecular imaging in drug development , 2008, Nature Reviews Drug Discovery.

[13]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[14]  Ralph Weissleder,et al.  A secreted luciferase for ex vivo monitoring of in vivo processes , 2008, Nature Methods.

[15]  X. Breakefield,et al.  A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER Stress , 2007, PloS one.

[16]  O. Laitinen,et al.  Brave new (strept)avidins in biotechnology. , 2007, Trends in biotechnology.

[17]  W. Pardridge shRNA and siRNA delivery to the brain. , 2007, Advanced drug delivery reviews.

[18]  K. F. Perry,et al.  Metabolic biotinylation of cell surface receptors for in vivo imaging , 2006, Nature Methods.

[19]  Nathan C Shaner,et al.  A guide to choosing fluorescent proteins , 2005, Nature Methods.

[20]  R. Blasberg,et al.  hNIS-IRES-eGFP Dual Reporter Gene Imaging , 2005, Molecular imaging.

[21]  I. Maclachlan,et al.  Factors limiting autogene‐based cytoplasmic expression systems , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  R. Weissleder,et al.  DTPA-bisamide-based MR sensor agents for peroxidase imaging. , 2005, Organic letters.

[23]  R. Weissleder,et al.  Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  M. Howarth,et al.  Site-specific labeling of cell surface proteins with biophysical probes using biotin ligase , 2005, Nature Methods.

[25]  J. Barbet,et al.  Recent advances in pretargeted radioimmunotherapy. , 2005, Current medicinal chemistry.

[26]  T. Crombleholme,et al.  Optimized large-scale production of high titer lentivirus vector pseudotypes. , 2004, Journal of virological methods.

[27]  Osman Ratib,et al.  OsiriX: An Open-Source Software for Navigating in Multidimensional DICOM Images , 2004, Journal of Digital Imaging.

[28]  R. Tsien,et al.  Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects , 2004, Cancer Research.

[29]  S. Kirkeby,et al.  Biotin carboxylases in mitochondria and the cytosol from skeletal and cardiac muscle as detected by avidin binding , 1993, Histochemistry.

[30]  E. Dadachova,et al.  The Na/I symporter (NIS): imaging and therapeutic applications. , 2004, Seminars in nuclear medicine.

[31]  M. Barry,et al.  Biotinylated gene therapy vectors , 2003, Expert opinion on biological therapy.

[32]  W. Heiss,et al.  Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. , 2003, Human gene therapy.

[33]  L. Allen Stem cells. , 2003, The New England journal of medicine.

[34]  T. K. Christopoulos,et al.  Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. , 2002, Analytical chemistry.

[35]  M. Barry,et al.  Metabolic biotinylation of secreted and cell surface proteins from mammalian cells. , 2001, Biochemical and biophysical research communications.

[36]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[37]  P. Beaumier,et al.  Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  F. D. De Braud,et al.  Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin , 1999, European Journal of Nuclear Medicine.

[39]  M. Ferrari,et al.  Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients , 1999, European Journal of Nuclear Medicine.

[40]  J. Wahlfors,et al.  Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: new tool for gene transfer studies and gene therapy. , 1998, BioTechniques.

[41]  B. Fritz,et al.  Effect of endogenous biotin on the applications of streptavidin and biotin in mice. , 1997, Nuclear medicine and biology.

[42]  E. Diamandis,et al.  The biotin-(strept)avidin system: principles and applications in biotechnology. , 1991, Clinical chemistry.

[43]  L. Shepp,et al.  Maximum Likelihood Reconstruction for Emission Tomography , 1983, IEEE Transactions on Medical Imaging.